Cancer Capital (CNCL) 10-Q 13 Aug 21 2021 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2021	Aug. 13, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2021
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--12-31
Entity File Number	000-32363
Entity Registrant Name	CANCER CAPITAL CORP
Entity Central Index Key	0001130889
Entity Tax Identification Number	91-1803648
Entity Incorporation, State or Country Code	WY
Entity Address, Address Line One	2157 S. Lincoln Street
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Salt Lake City
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84106
City Area Code	801
Local Phone Number	323-2395
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	true
Entity Common Stock, Shares Outstanding		6,150,000

Condensed Balance Sheets (Unaud

Condensed Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
CURRENT ASSETS
Cash	$ 1,198	$ 698
Total current assets	1,198	698
TOTAL ASSETS	1,198	698
CURRENT LIABILITIES
Accounts payable - related party	9,000	6,000
Accounts payable	3,000
Notes payable - related party	139,125	139,125
Notes payable	89,275	85,575
Accrued interest - related party	60,385	54,819
Accrued interest	51,019	47,519
Total current liabilities	351,804	333,038
Total liabilities	351,804	333,038
STOCKHOLDERS' DEFICIT
Common stock, $.001 par value; 20,000,000 shares authorized; 6,150,000 shares issued and outstanding	6,150	6,150
Additional paid-in capital	47,050	47,050
Accumulated deficit	(403,806)	(385,540)
Total stockholders' deficit	(350,606)	(332,340)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 1,198	$ 698

Condensed Balance Sheets (Una_2

Condensed Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jun. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	6,150,000	6,150,000
Common stock, shares outstanding	6,150,000	6,150,000

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Revenues
Operating expenses
General and administrative	3,800	2,695	9,200	8,110
Total operating expenses	3,800	2,695	9,200	8,110
Loss from operations	(3,800)	(2,695)	(9,200)	(8,110)
Other expense
Interest expense - related party	(2,783)	(2,663)	(5,566)	(5,204)
Interest expense	(1,789)	(1,651)	(3,500)	(3,302)
Total other expense	(4,572)	(4,314)	(9,066)	(8,506)
Loss before income taxes	(8,372)	(7,009)	(18,266)	(16,616)
Income tax expense
Net loss	$ (8,372)	$ (7,009)	$ (18,266)	$ (16,616)
Net loss per share - Basic and diluted	$ 0	$ 0	$ 0	$ 0
Weighted average shares outstanding - Basic and diluted	6,150,000	6,150,000	6,150,000	6,150,000

Condensed Statements of Stockho

Condensed Statements of Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance - December 31, 2020 at Dec. 31, 2019	$ 6,150	$ 47,050	$ (354,786)	$ (301,586)
Beginning balance, shares at Dec. 31, 2019				6,150,000
Net loss for the quarter ended - June 30, 2021			(9,607)	$ (9,607)
Balance - June 30, 2021 at Mar. 31, 2020	6,150	47,050	(364,393)	$ (311,193)
Ending balance, shares at Mar. 31, 2020				6,150,000
Balance - December 31, 2020 at Dec. 31, 2019	6,150	47,050	(354,786)	$ (301,586)
Beginning balance, shares at Dec. 31, 2019				6,150,000
Net loss for the quarter ended - June 30, 2021				$ (16,616)
Balance - June 30, 2021 at Jun. 30, 2020	6,150	47,050	(371,402)	$ (318,202)
Ending balance, shares at Jun. 30, 2020				6,150,000
Balance - December 31, 2020 at Mar. 31, 2020	6,150	47,050	(364,393)	$ (311,193)
Beginning balance, shares at Mar. 31, 2020				6,150,000
Net loss for the quarter ended - June 30, 2021			(7,009)	$ (7,009)
Balance - June 30, 2021 at Jun. 30, 2020	6,150	47,050	(371,402)	$ (318,202)
Ending balance, shares at Jun. 30, 2020				6,150,000
Balance - December 31, 2020 at Dec. 31, 2020	6,150	47,050	(385,540)	$ (332,340)
Beginning balance, shares at Dec. 31, 2020				6,150,000
Net loss for the quarter ended - June 30, 2021			(9,894)	$ (9,894)
Balance - June 30, 2021 at Mar. 31, 2021	6,150	47,050	(395,434)	$ (342,234)
Ending balance, shares at Mar. 31, 2021				6,150,000
Balance - December 31, 2020 at Dec. 31, 2020	6,150	47,050	(385,540)	$ (332,340)
Beginning balance, shares at Dec. 31, 2020				6,150,000
Net loss for the quarter ended - June 30, 2021				$ (18,266)
Balance - June 30, 2021 at Jun. 30, 2021	6,150	47,050	(403,806)	$ (350,606)
Ending balance, shares at Jun. 30, 2021				6,150,000
Balance - December 31, 2020 at Mar. 31, 2021	6,150	47,050	(395,434)	$ (342,234)
Beginning balance, shares at Mar. 31, 2021				6,150,000
Net loss for the quarter ended - June 30, 2021			(8,372)	$ (8,372)
Balance - June 30, 2021 at Jun. 30, 2021	$ 6,150	$ 47,050	$ (403,806)	$ (350,606)
Ending balance, shares at Jun. 30, 2021				6,150,000

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash Flows from Operating Activities
Net Loss	$ (18,266)	$ (16,616)
Adjustment to reconcile net loss to cash used by operating activities:
Expenses paid by related party	3,000	3,000
Changes in operating assets and liabilities:
Increase (decrease) in accounts payable	3,000	(1,200)
Increase in accrued interest - related party	5,566	5,204
Increase in accrued interest	3,500	3,302
Net cash used by operating activities	(3,200)	(6,310)
Cash Flows from Investing Activities
Net cash provided by investing activities
Cash Flows from Financing Activities
Proceeds from notes payable - related party		6,200
Proceeds from notes payable	3,700
Net cash provided by financing activities	3,700	6,200
Increase (decrease) in cash	500	(110)
Cash and cash equivalents at beginning of period	698	218
Cash and cash equivalents at end of period	1,198	108
Supplemental Cash Flow Information:
Cash paid for interest
Cash paid for income taxes

NOTE 1 - BASIS OF FINANCIAL STA

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION	NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION The accompanying unaudited condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed financial statements be read in conjunction with the Company's audited financial statements and notes thereto included in its December 31, 2020 Annual Report on Form 10-K. Operating results for the six months ended June 30, 2021 are not necessarily indicative of the results to be expected for year ending December 31, 2021.

NOTE 2 - GOING CONCERN

NOTE 2 - GOING CONCERN	6 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NOTE 2 - GOING CONCERN	NOTE 2 - GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has limited assets, has incurred losses since inception, has negative cash flows from operations, and has no revenue-generating activities. Its activities have been limited for the past several years and it is dependent upon financing to continue operations. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. It is management's plan to acquire or merge with other operating companies. The COVID-19 pandemic could have an impact on our ability to obtain financing to fund our operations. The Company is unable to predict the ultimate impact at this time.

NOTE 3 - RELATED PARTY TRANSACT

NOTE 3 - RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2021
Related Party Transactions [Abstract]
NOTE 3 - RELATED PARTY TRANSACTIONS	NOTE 3 - RELATED PARTY TRANSACTIONS During the six months ended June 30, 2021 and 2020, a shareholder invoiced the Company for consulting, administrative and professional services and out-of-pocket costs provided or paid on behalf of the Company totaling $ 3,000 3,000 9,000 6,000 During the six months ended June 30, 2021 and 2020, a shareholder loaned the Company $ 0 6,200 8 139,125 139,125 60,385 54,819

NOTE 4 - NOTES PAYABLE

NOTE 4 - NOTES PAYABLE	6 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
NOTE 4 - NOTES PAYABLE	NOTE 4 - NOTES PAYABLE During the six months ended June 30, 2021 and 2020, the Company was loaned $ 3,700 0 89,275 85,575 51,019 47,519

NOTE 5 - SUBSEQUENT EVENTS

NOTE 5 - SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2021
Subsequent Events [Abstract]
NOTE 5 - SUBSEQUENT EVENTS	NOTE 5 - SUBSEQUENT EVENTS The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined that there are no such events that would have a material impact on the financial statements.

NOTE 3 - RELATED PARTY TRANSA_2

NOTE 3 - RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Related Party Transactions [Abstract]
Consulting, administrative and professional costs provided for or paid on behalf of Company by shareholder	$ 3,000	$ 3,000
Amounts owed to shareholder	9,000		$ 6,000
Loans from shareholder	$ 0	$ 6,200
Interest rate on loans	8.00%	8.00%
Notes payable - related party	$ 139,125		139,125
Accrued interest on notes payable - related party	$ 60,385		$ 54,819

NOTE 4 - NOTES PAYABLE (Details

NOTE 4 - NOTES PAYABLE (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Debt Disclosure [Abstract]
Loans to the Company	$ 3,700	$ 0
Notes payable	89,275		$ 85,575
Accrued interest on notes payable	$ 51,019		$ 47,519